Concepedia

Stephen Hoge

SH

Statistics

Publications

6

Citations

845

H-Index

6

Active since

2007

Affiliations

Moderna Therapeutics (United States)(Current)

Alnylam Pharmaceuticals (United States)

Stephen Hoge is an author at Moderna Therapeutics (United States) specializing in drug delivery, pharmacy, and life sciences.

ORCID

Publications per year

2007–2020

6

Publications

6

Impact of mRNA chemistry and manufacturing process on innate immune activation

Jennifer Nelson, Elizabeth W. Sorensen, Shrutika Mintri et al. · Science Advances · 2020 · 341 citations · Full text

, , +17

Safety Evaluation of Lipid Nanoparticle–Formulated Modified mRNA in the Sprague-Dawley Rat and Cynomolgus Monkey

Maja Sedic, Joseph J. Senn, Andy Lynn et al. · Veterinary Pathology · 2017 · 188 citations

, , +17

The selenoproteome exhibits widely varying, tissue-specific dependence on selenoprotein P for selenium supply

Peter R. Hoffmann, Stephen Hoge, Ping-An Li et al. · Nucleic Acids Research · 2007 · 179 citations · Full text

, , +14

Accelerated Blood Clearance of Lipid Nanoparticles Entails a Biphasic Humoral Response of B-1 Followed by B-2 Lymphocytes to Distinct Antigenic Moieties

Gilles Besin, Jaclyn Milton, Staci Sabnis et al. · ImmunoHorizons · 2019 · 103 citations · Full text

, , +13

Nitinol Memory Rods Versus Titanium Rods: A Biomechanical Comparison of Posterior Spinal Instrumentation in a Synthetic Corpectomy Model

Patrick A. Massey, Stephen Hoge, Bradley G. Nelson et al. · Global Spine Journal · 2020 · 22 citations · Full text

, , +13

1–5 of 6